Literature DB >> 2323006

Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.

K Pelin-Enlund1, K Husgafvel-Pursiainen, L Tammilehto, M Klockars, K Jantunen, B I Gerwin, C C Harris, T Tuomi, E Vanhala, K Mattson.   

Abstract

Seven mesothelioma cell lines were established from clinical specimens from five patients with asbestos-related malignant pleural mesothelioma. The cells in culture show either epithelial or mixed epithelial/fibrosarcomatous growth with an average doubling time of 30 h. Giant multinucleated cells are common in all the cell lines, as well as long thin microvilli on the cell surfaces. All cell lines were cytokeratin positive and they stained negatively for monocyte-macrophage markers. All seven cell lines and one long-term tissue culture from a sixth mesothelioma patient were characterized cytogenetically. Karyotype analyses revealed complex structural and numerical abnormalities, primarily involving chromosome 1, 4, 5, 6, 7, 8, 9, 11, 12, 13 and 22. An excess of chromosome material of the short arm of chromosome 5 was seen consistently in six cell lines and in the long-term culture. In cell lines from four patients, changes in chromosome 13, mainly monosomy 13, were observed. The marker chromosomes observed in the early passages were conserved and few additional changes appeared in later passages. Six of the cell lines tested for tumorigenicity in athymic nude mice were weakly positive.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323006     DOI: 10.1093/carcin/11.4.673

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.

Authors:  Zhiwen Liu; Julius Klominek
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Reduced Fhit protein expression in human malignant mesothelioma.

Authors:  Lea Pylkkänen; Henrik Wolff; Tuula Stjernvall; Aija Knuuttila; Sisko Anttila; Kirsti Husgafvel-Pursiainen
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

3.  Mutations and altered expression of p16INK4 in human cancer.

Authors:  A Okamoto; D J Demetrick; E A Spillare; K Hagiwara; S P Hussain; W P Bennett; K Forrester; B Gerwin; M Serrano; D H Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

5.  Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.

Authors:  K Kinnula; K Linnainmaa; K O Raivio; V L Kinnula
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

6.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

7.  Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.

Authors:  Oluf Dimitri Røe; Adam Szulkin; Endre Anderssen; Arnar Flatberg; Helmut Sandeck; Tore Amundsen; Sten Even Erlandsen; Katalin Dobra; Stein Harald Sundstrøm
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

8.  Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

Authors:  Adam Szulkin; Gustav Nilsonne; Filip Mundt; Agata M Wasik; Pega Souri; Anders Hjerpe; Katalin Dobra
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

Review 10.  Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence.

Authors:  J C Barrett
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.